...
首页> 外文期刊>Angewandte Chemie >Inhibition of Pathogen Adhesion by Bacterial Outer Membrane-Coated Nanoparticles
【24h】

Inhibition of Pathogen Adhesion by Bacterial Outer Membrane-Coated Nanoparticles

机译:细菌外膜涂层纳米颗粒抑制病原体粘附性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Anti-adhesion therapies interfere with the bacterial adhesion to the host and thus avoid direct disruption of bacterial cycles for killing, which may alleviate resistance development. Herein, an anti-adhesion nanomedicine platform is made by wrapping synthetic polymeric cores with bacterial outer membranes. The resulting bacterium-mimicking nanoparticles (denoted "OM-NPs") compete with source bacteria for binding to the host. The "top-down" fabrication of OM-NPs avoids the identification of the adhesins and bypasses the design of agonists targeting these adhesins. In this study, OM-NPs are made with the membrane of Helicobacter pylori and shown to bind with gastric epithelial cells (AGS cells). Treatment of AGS cells with OM-NPs reduces H. pylori adhesion and such anti-adhesion efficacy is dependent on OM-NP concentration and its dosing sequence.
机译:抗粘连疗法干扰对宿主的细菌粘附,从而避免直接破坏细菌循环以杀死,这可能减轻抗性发育。 在此,通过用细菌外膜包裹合成聚合物芯来制备抗粘附纳米胺平台。 所得的细菌 - 模拟纳米颗粒(表示为“OM-NPS”)与源细菌竞争,用于与宿主结合。 OM-NPS的“自上而下”制造避免了粘附物的鉴定并绕过靶向这些粘合剂的激动剂的设计。 在该研究中,用幽门螺杆菌的膜制成OM-NP,并显示与胃上皮细胞(AGS细胞)结合。 用OM-NPS治疗AGS细胞降低了幽门螺杆菌粘附性,并且这种抗粘附功效取决于OM-NP浓度及其给药序列。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号